arrow
M

Marko Seppänen

University of Turku
H指数:47
被引数:7,016

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diagnostic performance of contrast-enhanced voiding ultrasonography and direct radionuclide cystography with physiologic bladder filling volumes in pediatric vesicoureteral reflux—a prospective study

对比增强排尿超声和直接放射性核素膀胱造影在儿科肾盂输尿管反流中的诊断性能比较——一项前瞻性研究

2026-03-150
OAAI
Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer

前瞻性比较18F-PSMA-1007 PET/CT与MRI在前列腺内肿瘤检测和高风险前列腺癌T分期中的表现,以组织病理学作为参考标准

2025-03-310
OA
Phase II Study Shows the Effect of Adenoviral Vascular Endothelial Growth Factor C and Lymph Node Transfer in Lymphedema
2024-08-122
PRE
Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease

膳食咖啡因与帕金森病的脑多巴胺能功能

2024-05-202
OAAI
A Prospective Comparison of 18F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE)

18f前列腺特异性膜抗原1007的正电子发射断层扫描计算机断层扫描,全身1.5 t磁共振成像与扩散加权成像以及单光子发射计算机断层扫描/计算机断层扫描与传统成像在原发性远处转移中的前瞻性比较前列腺癌 (晚期) 的分期

2021-08-0170
OAAI
Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer
2021-03-1333
OAAI